How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis.

OBJECTIVE To develop a clinical model for the prediction, at the first visit, of 3 forms of arthritis outcome: self-limiting, persistent nonerosive, and persistent erosive arthritis. METHODS A standardized diagnostic evaluation was performed on 524 consecutive, newly referred patients with early arthritis. Potentially diagnostic determinants obtained at the first visit from the patient's history, physical examination, and blood and imaging testing were entered in a logistic regression analysis. Arthritis outcome was recorded at 2 years' followup. The discriminative ability of the model was expressed as a receiver operating characteristic (ROC) area under the curve (AUC). RESULTS The developed prediction model consisted of 7 variables: symptom duration at first visit, morning stiffness for > or =1 hour, arthritis in > or =3 joints, bilateral compression pain in the metatarsophalangeal joints, rheumatoid factor positivity, anti-cyclic citrullinated peptide antibody positivity, and the presence of erosions (hands/feet). Application of the model to an individual patient resulted in 3 clinically relevant predictive values: one for self-limiting arthritis, one for persistent nonerosive arthritis, and one for persistent erosive arthritis. The ROC AUC of the model was 0.84 (SE 0.02) for discrimination between self-limiting and persistent arthritis, and 0.91 (SE 0.02) for discrimination between persistent nonerosive and persistent erosive arthritis, whereas the discriminative ability of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis was significantly lower, with ROC AUC values of 0.78 (SE 0.02) and 0.79 (SE 0.03), respectively. CONCLUSION A clinical prediction model was developed with an excellent ability to discriminate, at the first visit, between 3 forms of arthritis outcome. Validation in other early arthritis clinics is necessary.

[1]  B. Combe,et al.  Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage , 1997, Annals of the rheumatic diseases.

[2]  M. Weisman,et al.  When does rheumatoid arthritis begin and why do we need to know? , 2000, Arthritis and rheumatism.

[3]  Paul Wordsworth,et al.  Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. , 1994, Arthritis and rheumatism.

[4]  P. Bacon,et al.  Serum sulphydryl levels in early synovitis. , 1982, The Journal of rheumatology.

[5]  F. Breedveld,et al.  Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. , 1998, British journal of rheumatology.

[6]  A. Silman,et al.  Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. , 1996, The Journal of rheumatology.

[7]  A. van der Heide,et al.  The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs , 1996, Annals of Internal Medicine.

[8]  H. Zeidler,et al.  Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic , 1999, Annals of the rheumatic diseases.

[9]  W. Buchanan,et al.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. , 1968, The Quarterly journal of medicine.

[10]  S Greenland,et al.  Alternative models for ordinal logistic regression. , 1994, Statistics in medicine.

[11]  A. Silman,et al.  Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. , 1997, The Journal of rheumatology.

[12]  P. Dawes,et al.  The utility of the 1987 revised ARA criteria for rheumatoid arthritis in early synovitis. , 1991, British journal of rheumatology.

[13]  R. Winchester,et al.  The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. , 1992, Rheumatic diseases clinics of North America.

[14]  F. Breedveld,et al.  Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. , 1989, British journal of rheumatology.

[15]  P. Emery,et al.  Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status. , 1992, British journal of rheumatology.

[16]  B. Quilty,et al.  Prognostic criteria in rheumatoid arthritis: can we predict which patients will require specific anti-rheumatoid treatment? , 1997, Clinical and experimental rheumatology.

[17]  F. Wolfe,et al.  The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. , 1993, The Journal of rheumatology.

[18]  J. Hazes,et al.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.

[19]  A. Woolf,et al.  Predictors of the long-term outcome of early synovitis: a 5-year follow-up study. , 1991, British journal of rheumatology.

[20]  A. Feinstein,et al.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.

[21]  U. Brodin,et al.  Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. , 1995, The Journal of rheumatology.

[22]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[23]  J J Anderson,et al.  Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. , 2000, Arthritis and rheumatism.

[24]  V. Wright,et al.  Osteoarthritis in weight-bearing wrists? , 1993, British journal of rheumatology.

[25]  Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. , 1993, British journal of rheumatology.

[26]  J. Kassirer,et al.  Therapeutic decision making: a cost-benefit analysis. , 1975, The New England journal of medicine.

[27]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[28]  H K Genant,et al.  How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? , 1985, Arthritis and rheumatism.

[29]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[30]  B. Armstrong,et al.  Ordinal regression models for epidemiologic data. , 1989, American journal of epidemiology.

[31]  A. Silman,et al.  Diagnostic evaluation of classification criteria for RA and reactive arthritis , 2000 .

[32]  R. Madhok,et al.  Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study , 1998, Annals of the rheumatic diseases.

[33]  P N Valenstein,et al.  Evaluating diagnostic tests with imperfect standards. , 1990, American journal of clinical pathology.

[34]  A. Silman,et al.  Natural remission in inflammatory polyarthritis: issues of definition and prediction. , 1996, British journal of rheumatology.

[35]  D. Symmons,et al.  Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. , 1998, The Journal of rheumatology.

[36]  J. Hazes,et al.  HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. , 1999, Human immunology.

[37]  R. Grahame,et al.  Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. , 1993, The Journal of rheumatology.

[38]  D. Heijde,et al.  EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS , 1989, The Lancet.

[39]  G A Diamond,et al.  What price perfection? Calibration and discrimination of clinical prediction models. , 1992, Journal of clinical epidemiology.

[40]  A. Silman,et al.  The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. , 1998, The Journal of rheumatology.

[41]  D. Heijde,et al.  2 Can we predict aggressive disease , 1997 .

[42]  F. Arnett Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[43]  J. Kassirer,et al.  The threshold approach to clinical decision making. , 1980, The New England journal of medicine.